Clinical factors predicting return emergency department visits in chemotherapy-induced febrile neutropenia patients
Authors:
- 14 February 2023
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 67, 90-96
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Manejo de la infección y la neutropenia febril en el paciente con cáncer sólidoEnfermedades Infecciosas y Microbiología Clínica, 2017
- Revisit Rates and Associated Costs After an Emergency Department EncounterAnnals of Internal Medicine, 2015
- Can We Safely Discharge Low-Risk Patients With Febrile Neutropenia From the Emergency Department?Annals of Emergency Medicine, 2014
- Risk factors associated with complications in patients with chemotherapy‐induced febrile neutropenia in emergency departmentHematological Oncology, 2013
- Lactate: A Metabolic Key Player in CancerCancer Research, 2011
- Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patientsBritish Journal of Cancer, 2011
- Evaluation and Management of Treatment-Related Diarrhea in Patients with Advanced Cancer: A ReviewJournal of Pain and Symptom Management, 2008
- Shock index in diagnosing early acute hypovolemiaThe American Journal of Emergency Medicine, 2005
- Thrombocytopenia After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: An Unresolved Problem and Possible Approaches to Resolve ItJournal of Hematotherapy, 1996
- Lactate Homeostasis and Lactic AcidosisAnnals of Internal Medicine, 1980